Audit of adjuvant vinorelbine and cisplatin for patients with resected NSCLC

被引：0
|
作者：
Alzouebi, M. [1 ]
Fisher, P. [1 ]
Woll, P. J. [1 ]
Hatton, M. Q. [1 ]
Foran, B. [1 ]
Mohanamurali, J. [1 ]
Danson, S. [1 ]
机构：
[1] Weston Pk Hosp, Sheffield, S Yorkshire, England
来源：
LUNG CANCER | 2010年 / 67卷
关键词：
D O I：
10.1016/S0169-5002(10)70009-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [1] Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected NSCLC
    Sorensen, Steffen Filskov
    Carus, Andreas
    Meldgaard, Peter
    [J]. LUNG CANCER, 2015, 88 (02) : 167 - 173
  • [2] Survival data of postoperative adjuvant chemotherapy of cisplatin plus vinorelbine for completely resected NSCLC
    Kenmotsu, Hirotsugu
    Ohde, Yasuhisa
    Wakuda, Kazushige
    Nakashima, Kazuhisa
    Omori, Shota
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Endo, Masahiro
    Takahashi, Toshiaki
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [3] Real-World Outcomes of Adjuvant Cisplatin/ Vinorelbine vs Cisplatin/Pemetrexed in Resected Non-Squamous NSCLC
    Low, S. S. P.
    Barrie, C.
    Campbell, S.
    MacLennan, K.
    Philips, I.
    MacKean, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S560 - S561
  • [4] Survival Data of Postoperative Adjuvant Chemotherapy of Cisplatin plus Vinorelbine for Completely Resected NSCLC: A Retrospective Study
    Kenmotsu, Hirotsugu
    Ohde, Yasuhisa
    Ono, Akira
    Nakashima, Kazuhisa
    Omori, Shota
    Wakuda, Kazushige
    Naito, Tateaki
    Murakami, Haruyasu
    Kojima, Hideaki
    Takahashi, Shoji
    Isaka, Mitsuhiro
    Endo, Masahiro
    Takahashi, Toshiaki
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S866 - S866
  • [5] G-CSF improves the safety of adjuvant chemotherapy with cisplatin and vinorelbine in resected non small cell lung cancer (NSCLC): closing the audit loop
    Chiramel, J.
    Alzoubi, M.
    Fisher, P. M.
    Woll, P. J.
    [J]. LUNG CANCER, 2013, 79 : S12 - S12
  • [6] Lung adjuvant cisplatin evaluation (Lace Vinorelbine Project): Pooled analysis of adjuvant vinorelbine-cisplatin trials for completely resected non-small cell lung cancer (NSCLC)
    Douillard, Jean-Yves
    Tribodet, Helene
    His, Patricia
    Shepherd, Frances
    Ding, Keyue
    Winton, Timothy
    Le Chevalier, Thierry
    Spiro, Stephen
    Stephens, Richard
    Pignon, Jean-Pierre
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 213 - 213
  • [7] Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine after surgery for NSCLC.
    Sorensen, Steffen Filskov
    Carus, Andreas
    Meldgaard, Peter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Subgroup analysis of the phase III trial of adjuvant vinorelbine-cisplatin vs observation (Obs) in resected patients with NSCLC (ANITA): does efficacy vary by histology?
    Jean, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S334 - S334
  • [9] Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation
    Douillard, Jean-Yves
    Tribodet, Helene
    Aubert, Delphine
    Shepherd, Frances A.
    Rosell, Rafael
    Ding, Keyue
    Veillard, Anne-Sophie
    Seymour, Lesley
    Le Chevalier, Thierry
    Spiro, Stephen
    Stephens, Richard
    Pignon, Jean Pierre
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (02) : 220 - 228
  • [10] Efficacy and Safety of Erlotinib vs Vinorelbine/Cisplatin as Adjuvant Therapy for Stage IIIA EGFR Mutant NSCLC Patients
    Yue, D.
    Xu, S.
    Wang, Q.
    Li, X.
    Shen, Y.
    Zhao, H.
    Chen, C.
    Mao, W.
    Liu, W.
    Liu, J.
    Zhang, L.
    Ma, H.
    Li, Q.
    Yang, Y.
    Liu, Y.
    Chen, H.
    Wang, C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1789 - S1789
12345